Translational Molecular Imaging of Diabetes (Q58630430)

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Close to the bench as well as at the bedside: involving service users in all phases of translational research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Translational Medicine: A two-way road

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Imaging of β-cell mass and insulitis in insulin-dependent (Type 1) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Prediction and prevention of Type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Quantifying β-cells in health and disease: the past, the present, and the need

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

β-cell mass and turnover in humans: effects of obesity and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Relationship between beta-cell mass and fasting blood glucose concentration in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

What are the potential benefits of clinical beta-cell imaging in diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Advances in beta-cell imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Functional MR microimaging of pancreatic beta-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

MR imaging of pancreatic islets: tracking isolation, transplantation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Functional MRI characterization of isolated human islet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

β-Cell subcellular localization of glucose-stimulated Mn uptake by X-ray fluorescence microscopy: implications for pancreatic MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

High-resolution magnetic resonance imaging quantitatively detects individual pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Quantitative pancreatic β cell MRI using manganese-enhanced Look-Locker imaging and two-site water exchange analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Manganese-enhanced magnetic resonance imaging detects declining pancreatic β-cell mass in a cyclophosphamide-accelerated mouse model of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Pancreatic magnetic resonance imaging after manganese injection distinguishes type 2 diabetic and normoglycemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Noninvasive MRI of β-cell function using a Zn2+-responsive contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Imaging free zinc levels in vivo - what can be learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

A new gadolinium-based MRI zinc sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Synthesis and evaluation of fluorine-18 labeled glyburide analogs as beta-cell imaging agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Synthesis and evaluation of a glibenclamide glucose-conjugate: a potential new lead compound for substituted glibenclamide derivatives as islet imaging agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Synthesis and evaluation of radioiodinated substituted beta-naphthylalanine as a potential probe for pancreatic beta-cells imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Radioiodinated naphthylalanine derivatives targeting pancreatic beta cells in normal and nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

GLP-1 receptor antagonist as a potential probe for pancreatic beta-cell imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Near-infrared fluorescent probe for imaging of pancreatic beta cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Synthesis and evaluation of [18F]exendin (9-39) as a potential biomarker to measure pancreatic β-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

18F-Fallypride PET of pancreatic islets: in vitro and in vivo rodent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Visualizing pancreatic beta-cell mass with [11C]DTBZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Neurofunctional imaging of the pancreas utilizing the cholinergic PET radioligand [18F]4-fluorobenzyltrozamicol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Imaging of beta-cell mass and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Decreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Beta-cell imaging: opportunities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Beta-cell imaging: call for evidence-based and scientific approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

β-Cell mass imaging with DTBZ positron emission tomography: is it possible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Update on islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Five-year follow-up after clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Non-invasive detection of transplanted pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

MRI of transplanted pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

In vivo imaging of islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

In vivo imaging of autologous islet grafts in the liver and under the kidney capsule in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Positron-emission tomography imaging of early events after transplantation of islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Positron emission tomography in clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Radiolabeled glucagon-like peptide-1 analogues: a new pancreatic β-cell imaging agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

18F-Labelled exendin to image GLP-1 receptor-expressing tissues: from niche to blockbuster?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Glucagon-like peptide-1 receptor imaging for localization of insulinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Intraoperative ultrasound examination is useful for monitoring transplanted islets: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Role of imaging in clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

In Vivo Cellular Imaging for Translational Medical Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

MRI in diabetes: first results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7

Magnetic resonance imaging of gadolinium-labeled pancreatic islets for experimental transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40134-013-0019-7